The Vision

The Vision of Palobiofarma is to discover the first marketed drug based on a selective adenosine receptor modulator.

How do we achieve our vision

Palobiofarma focused internal resources on areas where lies the experience of the management team::

  • Virtual drug design
  • Medicinal Chemistry
  • In Vitro Pharmacology of adenosine
  • Physico-chemical characterization of the compounds
  • Intellectual Property

The remaining activities needed for the full compound characterization and the nomination of a development candidate, such as the pharmacology and toxicology tests, are carried out through partnerships with various companies (CROs), Research Centres and Universities.

Last News

This website uses cookies so that you have the best user experience. If you continue browsing you are giving your consent for the acceptance of the mentioned cookies and the acceptance of our Cookies policy.

Aviso de cookies